KMPharmaceutical Co Ltd
KOSDAQ:225430
KMPharmaceutical Co Ltd
Total Liabilities
KMPharmaceutical Co Ltd
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
KMPharmaceutical Co Ltd
KOSDAQ:225430
|
Total Liabilities
₩18B
|
CAGR 3-Years
21%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
AmorePacific Corp
KRX:090430
|
Total Liabilities
₩1.5T
|
CAGR 3-Years
11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
Amorepacific Group
KRX:002790
|
Total Liabilities
₩5.2T
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Cosmax Inc
KRX:192820
|
Total Liabilities
₩1.6T
|
CAGR 3-Years
23%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Total Liabilities
₩1.6T
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Total Liabilities
₩2.6T
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
36%
|
|
KMPharmaceutical Co Ltd
Glance View
KMPHARMACEUTICAL Co., Ltd. engages in the development and sale of oral health products. The company is headquartered in Pyeongtaek, Gyeonggi-Do. The company went IPO on 2015-10-08. Oral hygiene products include toothpaste, toothbrush and goggles. Cosmetic products consist of shampoo, body wash, sun cream, moisturizing cream, as well as lip balm and others. The firm distributes its products within domestic market and to overseas markets including North America, South America, Europe, China, Malaysia, Singapore, Vietnam and Australia.
See Also
What is KMPharmaceutical Co Ltd's Total Liabilities?
Total Liabilities
18B
KRW
Based on the financial report for Sep 30, 2025, KMPharmaceutical Co Ltd's Total Liabilities amounts to 18B KRW.
What is KMPharmaceutical Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
7%
Over the last year, the Total Liabilities growth was 13%. The average annual Total Liabilities growth rates for KMPharmaceutical Co Ltd have been 21% over the past three years , 7% over the past five years .
